BERLIN, Germany, December 14, 2023 / B3C newswire / --ProBioGen announced today that the Japan Patent Office (JPO) issued the first patent for the company’s DirectedLuck® technology. The powerful gene ...
ProBioGen, a leading CDMO of innovative solutions and services for biopharmaceutical development, announced the execution of services and license agreements with Mapp Biopharmaceutical, Inc. to ...
BERLIN, Germany, January 07, 2025 / Biotech Newswire / -- ProBioGen today announces the expansion of both protein and virus manufacturing at its Berlin headquarters. This includes the commissioning of ...